- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/56 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
Patent holdings for IPC class A61K 47/56
Total number of patents in this class: 369
10-year publication summary
|
4
|
19
|
27
|
26
|
31
|
38
|
38
|
28
|
26
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Hanmi Pharm. Co., Ltd. | 574 |
9 |
| Starpharma Pty Limited | 69 |
9 |
| Ascendis Pharma A/S | 182 |
6 |
| Code Biotherapeutics, Inc. | 22 |
6 |
| The Regents of the University of California | 20059 |
5 |
| Massachusetts Institute of Technology | 10102 |
5 |
| Ophidion Inc. | 11 |
5 |
| Selecta Biosciences, Inc. | 188 |
5 |
| Ashvattha Therapeutics, Inc. | 25 |
5 |
| The Johns Hopkins University | 5709 |
4 |
| Alnylam Pharmaceuticals, Inc. | 1142 |
4 |
| Halozyme, Inc. | 143 |
4 |
| National University Corporation Tokyo Medical and Dental University | 519 |
4 |
| University of Georgia Research Foundation, Inc. | 1035 |
4 |
| University of Maryland, Baltimore | 1027 |
4 |
| Dyne Therapeutics, Inc. | 249 |
4 |
| Barinthus Biotherapeutics North America, Inc. | 17 |
4 |
| AstraZeneca AB | 2908 |
3 |
| The Trustees of Columbia University in the City of New York | 3584 |
3 |
| Ajou University Industry-academic Cooperation Foundation | 1057 |
3 |
| Other owners | 273 |